WASHINGTON, DC – Congressman Brian Fitzpatrick (PA-01) and Congresswoman Debbie Dingell (MI-06) introduced the Knockout (K.O.) Cancer Act of 2023. The bipartisan legislation boosts funding for the National Cancer Institute by 25 percent over fiscal years 2024 through 2028 to more appropriately align with the current cancer mortality rates. Additionally, the Knockout Cancer Act asks Congress for a report on the devastating shortage of cancer drugs that is facing our nation.

"Over 5 decades ago, our nation declared war on cancer with the signing of the National Cancer Act. We have made significant progress in combatting this devastating disease, but there is still work yet to be done" said Congressman Fitzpatrick, co-chair of the House Cancer Caucus. "Current funding levels for research do not meet the alarming rate at which Americans are dying from this horrendous disease, and I am proud to lead the bipartisan Knockout (K.O) Cancer Act to ensure that the medical research community has adequate funding so that we can eventually defeat cancer once and for all."

“We must redouble our efforts to research, treat, and cure cancer, and address cancer drug shortages that are hurting patients across the country,” said Congresswoman Dingell. “The Knock Out Cancer Act will strengthen investments in research at the NIH to help develop innovative treatments and cures for cancers of all types, and I am proud to partner with Rep. Fitzpatrick on this legislation.”

“Research at AACI cancer centers lays the foundation for tomorrow’s cures,” said Association of American Cancer Institutes Executive Director Jennifer W. Pegher. “We support legislation and efforts by our congressional champions that aim to ensure that the life-saving work of our members is sustained by robust increases in federal funding.”

Read the text of the bill HERE.

###